Serum LDH and ALP isozyme activities in mice bearing solid Ehrlich carcinoma and/or treated with the maximum tolerated dose (MTD) of aloin

Disease Markers

Volumn 13, Issue 3, 1997, Pages 183-193

  Fahim, Fawzia A ^a   Esmat, Amr Y ^a   Mady, Essam A ^a   Amin, Magda A ^a  

^a Ain Shams University   (Egypt)

Author keywords

Aloin; ALP; Isozymes; LDH; Serum; Solid Ehrlich carcinoma

Indexed keywords

ALKALINE PHOSPHATASE; ALOIN; ANTHRAQUINONE; ANTINEOPLASTIC AGENT; INTESTINE ENZYME; ISOENZYME; LACTATE DEHYDROGENASE ISOENZYME;

ANIMAL EXPERIMENT; ARTICLE; BONE; CONTROLLED STUDY; EHRLICH ASCITES TUMOR; ENZYME ACTIVITY; FEMALE; INTRAMUSCULAR DRUG ADMINISTRATION; LACTATE DEHYDROGENASE BLOOD LEVEL; MAXIMUM PERMISSIBLE DOSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SOLID TUMOR;

ANIMALIA;

EID: 0030734048     PISSN: 02780240     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Alkesanndrov, N.N., Fradkin, S.Z. (1993). Ways of increasing the safety of the method of controlled hyperglycaemia-overacidification in overall treatment tumour. In: Ros, A.F. (Ed). Current problems of oncology and radiology, 3rd ed., New York:. Minak. pp.790-800.
2. Arison, R.N., Cassaro, J.A., Shenk, C.K. (1992). Factors which affect plasma LDH in tumour-hearing mice. Proc. Soc. Exp. Biol. Med., 210, 589-595.
3. Belfield, A, Goldberg, D.M. (1971). Revised assay for serum phenylphosphatase activity using 4- arnino antipyrine. Enzyme, 12, 561-568.
4. Burgess, E.A. (1991). LDH activity in plasma and interstitial fluid during growth of mouse tumours. Cancer, 42, 534-537.
5. Burny, D. (1990). Activities of key gluconeogenesis enzymes and glycogen synthesis in rat and human livers. Cancer Res., 38, 1317-1321.
6. Cahaud, G, Wrohlew ski, F. (1958). Colorimetric determination of LDH activity of the body fluids. Am. J. Clin. Puthol., 30, 234-237.
7. ElMerzabani, M.M., ElAaser, A.A., Osman, A.M., Ismael, N., AbuEIEla, F. (1989). Potentiation of therapeutic effect of methanesulphonate and protection against its organ cytotoxicity by vitamin C in Ehrlich ascitic carcinoma. J. Pharm. (Belg.). 44, 109-116.
8. Epstein, E. (1967). An indigogenic reaction for alkaline phosphatase in disk electrophoresis. Am. J. Clin. Puthol., 48, 530-542.
9. Fahim, F.A., Abd-Allah, N.M., Esrnal, A.Y. (1993a). Aloin: A natural anthraquinone with potential antiturnour activity J. Tumour Marker Oncol., 8, 27-34.
10. Fahim, F.A., Abd-Allah, N.M., Esnvat, A.Y. (1993b). Some metabolic aspects in normal and tumour bearing mice treated with a natural anthraquinone. J. Tumour Marker. Oncol., 8, 35-44.
11. Fahim, F.A., Esmat, A.Y., Mady, E.A., Amin, M.A. (1997). Pharmacokinetic and tumour studies of aloin (a natural anthraquinone) on mice bearing solid Ehrlich carcinoma. J. Tiimour Marker Oncol., in press.
12. Fisher, R. A., Yutes, F. (1943). Test of significance based on the normal distribution. In: Statistical tables for biological, agricultural and medical research. 2nd edn. Edinburgh: Oliver and Boyed.
13. Fountain, J.A., Parks, M.E., Dickey, A., McKee, R.W.(1970). Lactatedehydrogenaseisoenzymes in tissues of normal and Ehrlich -lettre ascites tumour-bearing Swiss mice. Cancer Res., 30, 998-1002.
14. Jacobson, K.B. (1992). Studies on plasma LDH in mice with myeloid leukemia. Cancer. 65, 2335-2451.
15. Kind, P.R., Gordon, M., Laverick, M., Slavin, B.M. (1985). The effect of C3H mouse mammary tumour on the levels of serum and urine analytes in vivo. Br. J. Cancer, 52, 607-611.
16. Koss, B., Greengard, O. (1982). Effect of neoplasms on the content and activity of alkaline phosphatase and γ-Glutamyl transpeptidase in uninvolvcd host tissues. Cancer Res., 42, 2146-2157.
17. Li, S., Obrien, D.A., Hou, E.W., Versala, J., Rockeil, D. (1989). Differential activity and synthesis of LDH isoenzymes in mouse spermatogenic cells. Biol. Reprod., 40, 173-176.
18. MacIntosh, L.C.,Thomson, A.W., Whiting, P.H.(1982). Serum biochemical changes in C.Parvum-injected mice bearing the Landschutz carcinoma. Br. J. Exp. Pathol. 63, 639-643.
19. Maekawa, M. (1990). Lactate dehydrogenase isoenzymes. J. Chromatography. 429, 373-380.
20. Mulla, M.Y., Leung, A., Moreno, R., Otero, R. (1990). Distribution of secretory component in hepatocytes and its mode of transfer into bile. Biochem. J., 210, 1210-1216.
21. Pescem A.J., Kaplan, L.A. (1987). In: Mosby, C.V. (Ed). Methods in clinical chemistry. 4th ed., Washington: Churchill Livingstone. pp. 1080-1092.
22. Riley, W., Wroblewski, D.E. (1980). The elevation of HBDH and LDH in serum of mice bearing solid tumours. J. Appl. Toxicol., 8, 233-236.
23. Rosalki, S.B. (1974). Standardization of isoenzymes assay with special reference to LDH electrophoresis. Clin. Biochem., 7, 29-33.
24. Thompson, W.R., Massimiano, P.S., Martin, A.J., Ghosh, B.C. (1987). Enzymes and antigens in liver tumours. In: Ghosh, B.C. (Ed), Tumour markers and tumour associated antigen, 2nd edn,. New York:. Academic Press, pp. 228-240.
25. Tietz, N.W. (1992). In: Fundamentals of clinical chemistry, 5th edn., Philadelphia: Saunders W.B. Co. pp. 1380-1385.
26. Vanhoof, V.O., Lepoutre, L.G., Hoylaerts, M.F., Cheving, R. (1990). Improved agarose electrophoretic method for separating alkaline phosphatase isoenzymes in serum. Clin. Chem., 34, 1857-1861.
27. Warburg, O. (1986). Locomotion of tumour cells. Science. 203, 598-603.
28. Wood, M.W. (1993). Anaerobic glycolysis in spontaneous and transplanted liver tumours of mice. J. Natl Cancer Inst., 96, 2520-2526.
29. Wright, E.J., Cawley, L.P., Eberhard, T.L. (1991). Functions of two forms of LDH in breast muscle of birds. Am. J. Clin. Path., 45, 737-742.
30. Zondag, H.A. (1991). Some aspects of LDH isoenzymes. In: Ruyssen, R. and Vandendrissch, L. (Eds), Enzymes in clinical chemistry, 4th edn. Amsterdam: Excepta Medica. pp. 120-145.